Scientists claim to have discovered a miracle compound which stops malaria in mice with a single, low dose.
The discovery could open a new avenue for the development of more effective antimalarials as parasites become resistant to existing drugs.
Researchers at MIT and Harvard found that a single dose in mice prevented infection from developing for the duration of the 30 day study.
By targeting a specific enzyme, it combatted early infection in the liver before parasites could spread to the blood in bigger numbers, the BBC reported.
The London School of Hygiene and Tropical Medicine s Professor David Baker said he was excited about the findings: The advantage of a single dose antimalarial is that it potentially reduces costs and removes the issue of patients not completing the course of treatment.
Malaria is transferred via bites from infected female mosquitoes.